Cancer Archive — Page 36 of 70
-
February 10, 2020
Imaging breast cancer cell size
A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy. -
February 6, 2020
Powering H. pylori pathogenesis
Timothy Cover and colleagues report new insights into the sources of energy used by a bacterial “machine” linked to the pathogenesis of stomach cancer. -
February 5, 2020
Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report
Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer. -
February 5, 2020
Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform. -
January 29, 2020
Protein research seeks to induce tumor regression
Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks. -
January 23, 2020
HDL-cholesterol and breast cancer risk
Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy. -
January 23, 2020
Study examines prostate cancer treatment decisions
A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.